Cancel
Known information
- Has over 18 years of experience working with biotechnology and pharmaceutical companies including Genentech, OncoMed, Juno Therapeutics, Celgene, and Kite
- Led the discovery and preclinical development programs for CAR T and TCR cell therapies targeting solid and hematological tumors at Juno and Kite
- Led the development of allogeneic cell therapy platforms leveraging T cells from both donor-derived sources and induced pluripotent stem cells at Kite
- Led R&D collaborations with genome editing companies including Editas Medicine and Sangamo Therapeutics
- Led monoclonal and bi-specific antibody discovery and engineering programs targeting cancer stem cell antigens at OncoMed Pharmaceuticals
- Is an inventor on numerous patents
- Has published papers in the fields of protein structure and engineering, immunology, and oncology
- Received a Ph.D. in Biochemistry from the University of Washington
About Notch Therapeutics
Notch Therapeutics is a biotechnology company that develops cellular immunotherapies for cancer treatment, utilizing a proprietary platform to engineer pluripotent stem cells into therapeutic cells.
Report inaccurate information
